Article

Dietary supplementation with a specific combination of high protein, leucine, and fish oil improves muscle function and daily activity in tumour-bearing cachectic mice

Wageningen University, The Netherlands.
British Journal of Cancer (Impact Factor: 4.82). 03/2009; 100(5):713-22. DOI: 10.1038/sj.bjc.6604905
Source: PubMed

ABSTRACT Cancer cachexia is characterised by metabolic alterations leading to loss of adipose tissue and lean body mass and directly compromises physical performance and the quality of life of cancer patients. In a murine cancer cachectic model, the effects of dietary supplementation with a specific combination of high protein, leucine and fish oil on weight loss, muscle function and physical activity were investigated. Male CD2F1 mice, 6-7 weeks old, were divided into body weight-matched groups: (1) control, (2) tumour-bearing, and (3) tumour-bearing receiving experimental diets. Tumours were induced by s.c. inoculation with murine colon adenocarcinoma (C26) cells. Food intake, body mass, tumour size and 24 h-activity were monitored. Then, 20 days after tumour/vehicle inoculation, the animals were killed and muscle function was tested ex vivo. Tumour-bearing mice showed reduced carcass, muscle and fat mass compared with controls. EDL muscle performance and total daily activity were impaired in the tumour-bearing mice. Addition of single nutrients resulted in no or modest effects. However, supplementation of the diet with the all-in combination of high protein, leucine and fish oil significantly reduced loss of carcass, muscle and fat mass (loss in mass 45, 52 and 65% of TB-con, respectively (P<0.02)) and improved muscle performance (loss of max force reduced to 55-64% of TB-con (P<0.05)). Moreover, total daily activity normalised after intervention with the specific nutritional combination (50% of the reduction in activity of TB-con (P<0.05)). In conclusion, a nutritional combination of high protein, leucine and fish oil reduced cachectic symptoms and improved functional performance in cancer cachectic mice. Comparison of the nutritional combination with its individual modules revealed additive effects of the single components provided.

Download full-text

Full-text

Available from: Eline M van der Beek, Jul 04, 2015
0 Followers
 · 
166 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Fatigue is a common occurrence in cancer patients regardless of tumor type or anti-tumor therapies and is an especially problematic symptom in persons with incurable tumor disease. In rodents, tumor-induced fatigue is associated with a progressive loss of skeletal muscle mass and increased expression of biomarkers of muscle protein degradation. The purpose of the present study was to determine if muscle wasting and expression of biomarkers of muscle protein degradation occur in the hearts of tumor-bearing mice, and if these effects of tumor growth are associated with changes in cardiac function. The colon26 adenocarcinoma cell line was implanted into female CD2F1 mice and skeletal muscle wasting, in vivo heart function, in vitro cardiomyocyte function, and biomarkers of muscle protein degradation were determined. Expression of biomarkers of protein degradation were increased in both the gastrocnemius and heart muscle of tumor-bearing mice and caused systolic dysfunction in vivo. Cardiomyocyte function was significantly depressed during both cellular contraction and relaxation. These results suggest that heart muscle is directly affected by tumor growth, with myocardial function more severely compromised at the cellular level than what is observed using echocardiography.
    Life sciences 02/2011; 88(9-10):406-10. DOI:10.1016/j.lfs.2010.12.010 · 2.30 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: This paper discusses the assessment of strategic market power in power systems. In general, market power is the ability of a particular seller or group of sellers to maintain prices profitably above competitive levels for significant periods of time. In assessing market power for power systems, the transmission network usually plays a crucial role in determining the market size, and hence the market concentration. The presence of congestion in the transmission system can significantly limit market size, and hence increase the potential for market participants to exercise market power. This paper considers the ability of market participants to make strategic use of the transmission network to deliberately induce congestion, and hence to increase the likelihood that the participants can exercise market power. The paper defines the problem, introduces methods for assessing the potential for such strategic behavior, and demonstrates results using a sample system
    Power Engineering Society 1999 Winter Meeting, IEEE; 01/1999
  • Advances in Immunology 02/2002; 80:183-202. DOI:10.1016/S0065-2776(02)80015-3 · 5.53 Impact Factor